This major sporting event doesn't just have to disrupt your team. Photo via Getty Images

For sports enthusiasts, one of the most popular competitions that attracts tens of millions of viewers is here – March Madness, the NCAA Division I Men’s Basketball Tournament. As fans gear up for three weeks of action, employers are also excited, but for very different reasons.

March Madness can be a distraction in the workplace that hinders productivity. According to Challenger, Gray & Christmas, Inc., lost productivity during the tournament can cost employers over $13 billion, with nearly 50 percent of workers spending more than six hours of work time on March Madness activities. With an increase in hybrid/remote workers, the stage is set for more employees to view games during the workday, leading to higher levels of productivity losses.

Although these numbers are staggering, savvy employers can leverage March Madness to promote team building and boost employee engagement, which can have a positive impact on long-term success. Below are four tips for business leaders to consider as they embrace March Madness.

Embrace the reality

Employers should accept the reality that employees will participate in March Madness activities regardless of company policies. With access to the tournament through streaming services, updates on websites, social media discussions, bracket activities and more autonomy in remote situations, it is impossible for employers to monitor.

Companies that embrace the madness will experience less frustration for management and greater appreciation from workers. More importantly, it demonstrates a human side when companies incorporate current events into daily interactions that support the interests of employees, along with business needs.

Understand the reality

While the tournament is a short-term event, the way employers handle it can have long-term benefits. As countless businesses look for ways to extend the culture to remote workers, leaders can rally around this event to facilitate more interactions and develop stronger bonds, further connecting employees to the company.

With proper management, levels of employee engagement, morale, performance and retention increase, which can have a dramatic effect on future initiatives and the bottom line. When leaders extend trust and enable employees the flexibility to enjoy the tournament in some manner, they are investing in the future.

Set guidelines

Business leaders should be proactive about March Madness by recognizing employees’ excitement and setting guidelines. A best practice is to distribute an email about the tournament and expectations surrounding activities, along with a reminder that sports gambling is illegal in the workplace.

For those coming into the office, enable televisions to display games so employees can get quick updates or watch games during breaks/lunch hours. When employees understand expectations, they are better able to manage their responsibilities and appropriately share in the festivities, leading to continued performance and improved morale.

Nurture the culture

March Madness is an ideal way to incorporate relevant activities that nurture the culture and involve remote employees. Encourage employees to wear jerseys of their favorite teams on game days, take pictures and post them on the intranet/social media. Hold a contest for the best-decorated workspace that includes home offices.

Hosting virtual events like bracket-picking breaks, game-watching gatherings and hoops happy hours offer groups a chance to connect. Awarding gifts cards to employees who pick winning brackets for the Sweet Sixteen, Elite Eight and Final Four promotes friendly competition. A PTO raffle for picking The Big Dance national champion is a bonus. When employees are part of a fun environment, it increases camaraderie and team building that nurtures the culture.

As the hype around March Madness builds and people scurry to finalize their brackets, employers should join in on the excitement and seize the opportunity to bring remote teams closer to the fold, promote the culture and position the company for continued success.

------

Jill Chapman is a senior performance consultant with Insperity, a leading provider of human resources and business performance solutions.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Modular nuclear reactor co. NuScale Power moves into Houston market

New to Hou

The nuclear energy renaissance continues in Texas with an announcement by NuScale Power. The Oregon-based provider of proprietary and innovative advanced small modular reactor (SMR) nuclear technology announced in April it would be opening office space in Houston’s CityCentre.

“Opening this space in Houston underscores our commitment to meeting rising energy demand with safe, scalable nuclear technology,” John Hopkins, NuScale president and CEO, said in a news release. “This move expands our presence in a key market for partners, prospective customers, and stakeholders in addition to positioning us for the future as we focus on the near-term deployment of our industry-leading technology. Texas is leading the way in embracing advanced nuclear for grid resilience and industrial decarbonization, and we’re proud to expand our footprint and capabilities in this important region.”

Interest in nuclear power has been growing in recent years thanks to tensions with oil-rich nations, concerns about man-made climate change from fossil fuels, and the rapidly increasing power needs of data centers. Both Dow and Texas A&M University have announced expanded nuclear power projects in the last year, with an eye of changing the face of Texas’s energy industry through smaller, safer fission reactors.

Enter NuScale, founded in 2007 from technology developed at the University of Oregon. Their modular SMR technology generates 77 megawatts and is one of the only small modular reactors (SMR) to receive design approval from the U.S. Nuclear Regulatory Commission (NRC). These advances have led to runaway success for NuScale, whose stock has risen by more than 1,670 percent since the start of 2024.

The new operations campus in CityCentre is expected to facilitate the movement, installation and coordination of NuScale technology into the various energy systems. Typically, SMRs are used for off-grid installations, desalination operations, mining facilities and similar areas that lack infrastructure. However, the modularity means that they can be easily deployed to a variety of areas.

It comes none too soon. ERCOT projects that Texas data centers alone will require 77,965 megawatts by 2030.

---

This article first appeared on EnergyCapitalHTX.com.

Pharma giant considers Houston for $1 billion manufacturing campus

in the works

Another pharmaceutical giant is considering Houston’s Generation Park for a manufacturing hub.

According to a recent filing with the Texas Jobs, Energy, Technology and Innovation (JETI) program, Bristol Myers Squibb Co. is considering the northeast Houston management district for a new $1 billion multi-modal pharmaceutical manufacturing campus.

If approved, the campus, known as Project Argonaut, could create 489 jobs in Texas by 2031. Jobs would include operations technicians, engineering roles, administrative and management roles, production specialists, maintenance support, and quality control/assurance. The company predicts annual average wages for these positions to be around $96,000, according to the filing.

The project currently includes the 600,000-square-foot facility, but according to the filing, Bristol Myers Squibb “envisions this site growing in scale and capability well beyond its opening configuration."

The Texas JETI program offers companies temporary school property tax limitations in exchange for major capital investment and job creation. E.R. Squibb & Sons LLC applied for a 10-year tax abatement agreement in the Sheldon Independent School District.

The agreement promises a $ 1 billion investment. Construction would begin in 2027 and wrap in 2029.

“The proposed project reflects [Bristol Myers Squibb Co.’s] enduring commitment to bringing innovative medicines to patients and ensuring the long-term supply reliability they depend on,” the filing says. “The proposed project is purpose-built to support and manufacture medicines spanning multiple therapeutic areas and modalities, positioning the site as a long-term launch and commercial campus for decades to come. These medicines will provide therapies to the [Bristol Myers Squibb Co.’s] patients located in markets both nationally and internationally.”

The Fortune 100 company is considering 16 other cities for the new manufacturing facility in the Central and Eastern markets in the U.S. According to the Houston Chronicle, Bristol Myers Squibb Co is still in the “evaluation process” for its potential manufacturing site.

Last fall, Eli Lilly and Co. selected Generation Park for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.

Houston health tech co. lands NIH grant for AI cancer prediction tool

fresh funding

Houston-based CellChorus and Stanford Medicine were recently awarded a Phase I Small Business Innovation Research grant for the company's AI platform to test how certain cancer patients will respond to therapies.

The funding comes from the National Cancer Institute of the National Institutes of Health. According to a filing, the grant totaled just under $400,000.

CellChorus, which spun out from the University of Houston’s Technology Bridge, has developed TIMING (Time-lapse Imaging Microscopy In Nanowell Grids), which analyzes the behavior of thousands of individual immune cells over time and can identify early indicators of treatment success or failure.

The company will work with Stanford's Dr. David Miklos and Dr. Saurabh Dahiya, who have built the Bone Marrow Transplantation and Cell Therapy Biobank. The biobank manages and stores biological samples from patients treated at their clinic and in clinical trials.

"Predicting which patients will achieve durable responses after CAR-T therapy remains one of the most important challenges in the field,” Miklos said in a news release. “We aim to uncover functional cellular signatures that can guide treatment decisions and improve patient outcomes.”

The project will specifically profile cells from patients with relapsed/refractory large B-cell lymphoma (r/rLBCL). According to CellChorus, only about half of r/rLBCL patients who receive CAR-T therapy "achieve a durable, long-term remission." Others do not respond to therapy or experience relapse.

“The sooner we know whether a cancer therapy is working, the better. To maximize patient benefit, we need technology that can provide a robust and early prediction of response to therapy. The technology needs to be scalable, cost-efficient, and capable of rapid turnaround times,” Rebecca Berdeaux, chief scientific officer of CellChorus, added in the release. “We are excited to work with Drs. David Miklos and Saurabh Dahiya and their colleagues on this very important project.”

CellChorus has previously received SBIR grants from federal agencies, including a $2.5 million award in 2024 from its National Center for Advancing Translational Sciences (NCATS) and a $2.3 million SBIR Fast-Track award from the National Institute of General Medical Sciences in 2023.